230 related articles for article (PubMed ID: 24821727)
1. Role of promyelocytic leukemia zinc finger (PLZF) in cell proliferation and cyclin-dependent kinase inhibitor 1A (p21WAF/CDKN1A) gene repression.
Choi WI; Kim MY; Jeon BN; Koh DI; Yun CO; Li Y; Lee CE; Oh J; Kim K; Hur MW
J Biol Chem; 2014 Jul; 289(27):18625-40. PubMed ID: 24821727
[TBL] [Abstract][Full Text] [Related]
2. Promyelocytic leukemia zinc finger-retinoic acid receptor α (PLZF-RARα), an oncogenic transcriptional repressor of cyclin-dependent kinase inhibitor 1A (p21WAF/CDKN1A) and tumor protein p53 (TP53) genes.
Choi WI; Yoon JH; Kim MY; Koh DI; Licht JD; Kim K; Hur MW
J Biol Chem; 2014 Jul; 289(27):18641-56. PubMed ID: 24821728
[TBL] [Abstract][Full Text] [Related]
3. Regulation of the cyclin-dependent kinase inhibitor 1A gene (CDKN1A) by the repressor BOZF1 through inhibition of p53 acetylation and transcription factor Sp1 binding.
Kim MK; Jeon BN; Koh DI; Kim KS; Park SY; Yun CO; Hur MW
J Biol Chem; 2013 Mar; 288(10):7053-64. PubMed ID: 23329847
[TBL] [Abstract][Full Text] [Related]
4. A novel POK family transcription factor, ZBTB5, represses transcription of p21CIP1 gene.
Koh DI; Choi WI; Jeon BN; Lee CE; Yun CO; Hur MW
J Biol Chem; 2009 Jul; 284(30):19856-66. PubMed ID: 19491398
[TBL] [Abstract][Full Text] [Related]
5. ZBTB2, a novel master regulator of the p53 pathway.
Jeon BN; Choi WI; Yu MY; Yoon AR; Kim MH; Yun CO; Hur MW
J Biol Chem; 2009 Jul; 284(27):17935-46. PubMed ID: 19380588
[TBL] [Abstract][Full Text] [Related]
6. Proto-oncogene FBI-1 represses transcription of p21CIP1 by inhibition of transcription activation by p53 and Sp1.
Choi WI; Jeon BN; Yun CO; Kim PH; Kim SE; Choi KY; Kim SH; Hur MW
J Biol Chem; 2009 May; 284(19):12633-44. PubMed ID: 19244234
[TBL] [Abstract][Full Text] [Related]
7. Critical residues within the BTB domain of PLZF and Bcl-6 modulate interaction with corepressors.
Melnick A; Carlile G; Ahmad KF; Kiang CL; Corcoran C; Bardwell V; Prive GG; Licht JD
Mol Cell Biol; 2002 Mar; 22(6):1804-18. PubMed ID: 11865059
[TBL] [Abstract][Full Text] [Related]
8. Fusion protein of retinoic acid receptor alpha with promyelocytic leukemia protein or promyelocytic leukemia zinc finger protein recruits N-CoR-TBLR1 corepressor complex to repress transcription in vivo.
Tomita A; Buchholz DR; Obata K; Shi YB
J Biol Chem; 2003 Aug; 278(33):30788-95. PubMed ID: 12794076
[TBL] [Abstract][Full Text] [Related]
9. The proto-oncoprotein FBI-1 interacts with MBD3 to recruit the Mi-2/NuRD-HDAC complex and BCoR and to silence p21WAF/CDKN1A by DNA methylation.
Choi WI; Jeon BN; Yoon JH; Koh DI; Kim MH; Yu MY; Lee KM; Kim Y; Kim K; Hur SS; Lee CE; Kim KS; Hur MW
Nucleic Acids Res; 2013 Jul; 41(13):6403-20. PubMed ID: 23658227
[TBL] [Abstract][Full Text] [Related]
10. AML-1/ETO fusion protein is a dominant negative inhibitor of transcriptional repression by the promyelocytic leukemia zinc finger protein.
Melnick A; Carlile GW; McConnell MJ; Polinger A; Hiebert SW; Licht JD
Blood; 2000 Dec; 96(12):3939-47. PubMed ID: 11090081
[TBL] [Abstract][Full Text] [Related]
11. HDAC4 represses p21(WAF1/Cip1) expression in human cancer cells through a Sp1-dependent, p53-independent mechanism.
Mottet D; Pirotte S; Lamour V; Hagedorn M; Javerzat S; Bikfalvi A; Bellahcène A; Verdin E; Castronovo V
Oncogene; 2009 Jan; 28(2):243-56. PubMed ID: 18850004
[TBL] [Abstract][Full Text] [Related]
12. Components of the SMRT corepressor complex exhibit distinctive interactions with the POZ domain oncoproteins PLZF, PLZF-RARalpha, and BCL-6.
Wong CW; Privalsky ML
J Biol Chem; 1998 Oct; 273(42):27695-702. PubMed ID: 9765306
[TBL] [Abstract][Full Text] [Related]
13. Ligand-dependent corepressor (LCoR) recruitment by Kruppel-like factor 6 (KLF6) regulates expression of the cyclin-dependent kinase inhibitor CDKN1A gene.
Calderon MR; Verway M; An BS; DiFeo A; Bismar TA; Ann DK; Martignetti JA; Shalom-Barak T; White JH
J Biol Chem; 2012 Mar; 287(12):8662-74. PubMed ID: 22277651
[TBL] [Abstract][Full Text] [Related]
14. KR-POK interacts with p53 and represses its ability to activate transcription of p21WAF1/CDKN1A.
Jeon BN; Kim MK; Choi WI; Koh DI; Hong SY; Kim KS; Kim M; Yun CO; Yoon J; Choi KY; Lee KR; Nephew KP; Hur MW
Cancer Res; 2012 Mar; 72(5):1137-48. PubMed ID: 22253232
[TBL] [Abstract][Full Text] [Related]
15. Histone deacetylase associated with mSin3A mediates repression by the acute promyelocytic leukemia-associated PLZF protein.
David G; Alland L; Hong SH; Wong CW; DePinho RA; Dejean A
Oncogene; 1998 May; 16(19):2549-56. PubMed ID: 9627120
[TBL] [Abstract][Full Text] [Related]
16. SMRT corepressor interacts with PLZF and with the PML-retinoic acid receptor alpha (RARalpha) and PLZF-RARalpha oncoproteins associated with acute promyelocytic leukemia.
Hong SH; David G; Wong CW; Dejean A; Privalsky ML
Proc Natl Acad Sci U S A; 1997 Aug; 94(17):9028-33. PubMed ID: 9256429
[TBL] [Abstract][Full Text] [Related]
17. The ETO protein disrupted in t(8;21)-associated acute myeloid leukemia is a corepressor for the promyelocytic leukemia zinc finger protein.
Melnick AM; Westendorf JJ; Polinger A; Carlile GW; Arai S; Ball HJ; Lutterbach B; Hiebert SW; Licht JD
Mol Cell Biol; 2000 Mar; 20(6):2075-86. PubMed ID: 10688654
[TBL] [Abstract][Full Text] [Related]
18. The tumor suppressor p53 and histone deacetylase 1 are antagonistic regulators of the cyclin-dependent kinase inhibitor p21/WAF1/CIP1 gene.
Lagger G; Doetzlhofer A; Schuettengruber B; Haidweger E; Simboeck E; Tischler J; Chiocca S; Suske G; Rotheneder H; Wintersberger E; Seiser C
Mol Cell Biol; 2003 Apr; 23(8):2669-79. PubMed ID: 12665570
[TBL] [Abstract][Full Text] [Related]
19. Reduced retinoic acid-sensitivities of nuclear receptor corepressor binding to PML- and PLZF-RARalpha underlie molecular pathogenesis and treatment of acute promyelocytic leukemia.
Guidez F; Ivins S; Zhu J; Söderström M; Waxman S; Zelent A
Blood; 1998 Apr; 91(8):2634-42. PubMed ID: 9531570
[TBL] [Abstract][Full Text] [Related]
20. A role of Miz-1 in Gfi-1-mediated transcriptional repression of CDKN1A.
Liu Q; Basu S; Qiu Y; Tang F; Dong F
Oncogene; 2010 May; 29(19):2843-52. PubMed ID: 20190815
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]